Based on the improved immune microenvironment, the infiltration of CD8+ T cells in the tumor periphery was increased by the 747 treatment, leading to better efficiency of immunotherapy of the HCC [121]. This evidence concerns the gene CD8A and hepatocellular carcinoma.